As well as describing MAIT-cell dysfunction in patients, we associate this with enhanced PD-1 upregulation upon specific stimulation, and demonstrate that PD-1 blockade can lead to enhanced MAIT-cell cytotoxicity against a prostate cancer cell line in response to a MR-1 ligand. Here, MR1 is linked to prostate carcinoma.